03 May 07 Insecticides India Limited IPO
Insecticides India Ltd, a leading Indian manufacturer and distributor of plant protection chemicals and house hold pesticides, will be entering the Indian capital market with an initial public offering of 32.10 lakh shares of Rs 10 each at a premium to be decided through a book building process. The Insecticides India Limited IPO opens for subscription on May 07, 2007 and closes for subscription on May 11, 2007.
Insecticides India Limited has spearheaded the endeavor to bring home world-class quality new generation products through latest technological developments. Insecticides India Limited has entered into technical collaboration with global giants AMVAC, USA for THIMET, which is India’s most popular generic pesticide. Thimet, being the first choice of Indian Farmers, has helped Insecticides India Ltd in further strengthening their base at the grass root level.
As per the Insecticides India Ltd. IPO Prospectus, the proceeds of the IPO will be used to set up a formulations plant at Samba and set up a manufacturing technical plant and research and development facility at Chopanki.
UTI securities is the lead manager of the Insecticides India Limited IPO and Intime spectrum is the registrar for the IPO. Post IPO Insecticides India Limited will list on both the NSE and the BSE. However, Insecticides India Limited is not eligible for entry into the futures and options segment.
For updates on the subscription / oversubscription ratio of Insecticides India Limited IPO and to know the allotment and listing date of Insecticides India Limited IPO, do check this blog everyday.
Insecticides India Limited IPO Prospectus
For more information, read the IPO prospectus of the Insecticides India Limited IPO Issue.
Related Posts
Reader's Comments
Leave a Comment
Dear bullishindian,
Is it adviseable to invest in “Insecticides India” now. Is it oversubscribed ?
Hello Rao, The IPO is under subscribed as of now. It has been subscribed less than 0.2 times the issue size. It’s better not to invest in the Insecticides India IPO, if it doesnt get oversubscribed by atleast 3 times by 2 PM today
hi bullish indian,
thanks to your advised.
after reading your eight tips ,i have saved myself from being locking money into binanai and insectiside india like i locked in fortis.
i need your advise.
i want to buy nearabout 1000 RPL shares ( for long term say atleast 4 years) and 2500 RNRL sahres for same duration.
At what price shall i get them. i was planning to buy at 78 and 25 respectively, but they have skyrocketed to 95 and 31.
please advice as i don’t want to ruin my hard earned money
I need ur advise regarding indusind bank shares as my father have bought last year about 200 shares for Rs.70 each.
Please advise me whether to sell or to hold these shares.
Sorry Sakthi, I don’t track that counter
Hello Amit, RPL is a low beta stock. It won’t move much either ways. RPL is a safe Low risk, low return stock. I don’t track RNPL
On what basis do you say that Insecticides India IPO was not worth subscribing? Just because Institutional Investors are not subscribing you draw the conclusion that it is not worth subscribing. Why would Institutional Investors subscribe to an issue as small as 37 Cr. with just 32 lac shares on offer? Have you checked the financials of the Co.? Absolute EPS of Rs.12 on 9-monthly basis on post-issue capital.
@ Rishi – What makes you think Institutional Investors don’t like small issues? When a 60 crore IPO issue like the nitin fire ipo can get huge institutional investor subscription, can’t the 40 crore Insecticides India IPO issue get even half of that? C’mon institutional investor category was undersubscribed. I did have a look at the balance sheet and so would have all the institutional investors. A good fundamental analyst would know that a balance sheet is like a mini skirt— What it reveals is interesting, what it hides is mind boggling. There is much more to the balance sheet than just EPS and PE ratio.
My hypothesis is this
1) Institutional investors have acess to a lot more information than the retail investors
2) Most retail investors invest for listing gains and sell on the day of listing. On the other hand most institutional investors are long term investors. As you say, if the institutional investors dont intend to buy insectisides India stock, because the floating stock and the free float market capitalisation is low, then they won’t buy in the secondary market as well. Then where will the counter find buying support on the day of listing when retail investors decide to sell of the shares alloted to them?
These are my personal views based on my past experience. I’m not forcing my views on others. It’s just my opinion!
to Bullish Indian: Pls point out what you saw in the Bal Sheet that was missed by me. It would definitely enhance my knowledge level, which I shall also make note of before investing in future. Infact there are ‘n’ no. of examples when Institutional Investors sell the stock on the day of listing. This Long Term investing idea is only in the books. Whoever makes money sells the stock.